Isolation and identification of Rhizomucor pusillus from pleural zygomycosis in an immunocompetent patient

Medical Mycology

Volumn 47, Issue 8, 2009, Pages 869-873

  Kimura, Masatomo ^a   Udagawa, Shun Ichi ^b   Makimura, Koichi ^c   Satoh, Kazuo ^c   Toyazaki, Noritsuna ^d   Ito, Hiroyuki ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPAN FOOD RESEARCH LABORATORIES   (Japan)

^c TEIKYO UNIVERSITY   (Japan)

^d Hyogo Health Service Association   (Japan)

Author keywords

Human; Immunocompetent; Pleura; Rhizomucor pusillus

Indexed keywords

ANTIBIOTIC AGENT; AMPHOTERICIN B; ANTIFUNGAL AGENT; FUNGAL DNA;

ADULT; ARTICLE; BLISTER; CASE REPORT; CATHETER INFECTION; CATHETER REMOVAL; DRUG WITHDRAWAL; FOLLOW UP; FUNGUS CULTURE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; GENERAL CONDITION IMPROVEMENT; HUMAN; IMMUNOCOMPETENCE; LUNG MYCOSIS; LUNG RESECTION; MALE; MUCORMYCOSIS; PLEURA FLUID; PLEURISY; PNEUMOTHORAX; RHIZOMUCOR; RHIZOMUCOR PUSILLUS; TREATMENT WITHDRAWAL; ZYGOMYCETES; CYTOLOGY; FUNGUS SPORE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; ISOLATION AND PURIFICATION; LUNG; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PATHOLOGY; PLEURAL DISEASES; POLYMERASE CHAIN REACTION; RADIOGRAPHY; YOUNG ADULT; ZYGOMYCOSIS;

FUNGI; RHIZOMUCOR PUSILLUS; ZYGOMYCETES;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; DNA, FUNGAL; HUMANS; IMMUNOCOMPETENCE; IMMUNOHISTOCHEMISTRY; LUNG; MALE; MICROBIAL SENSITIVITY TESTS; PLEURAL DISEASES; POLYMERASE CHAIN REACTION; RHIZOMUCOR; SPORES, FUNGAL; YOUNG ADULT; ZYGOMYCOSIS;

EID: 73649083335     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693780903059485     Document Type: Article

References (27)

1. Kwon-Chung KJ, Bennett JE. Mucormycosis. In: Kwon-Chung KJ, Bennett JE (eds). Medical Mycology. Philadelphia, PA: Lea & Febiger 1992: 524-559.
2. Roden MM, Zaoutis TE, Bushanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41: 634-653.
3. Freifeld AG, Iwen PC. Zygomycosis. Semi Respir Crit Care Med 2004; 25: 221-331.
4. Fukuzawa M, Inaba H, Hayama M, et al. Improved detection of medically important fungi by immunoperoxidase staining with polyclonal antibodies. Virch Arch 1995; 427: 407-414.
5. Shipper MAA. On the genera R hizomucor and Parasitella. Stud Mycol 1978; 17: 53-71.
6. de Hoog GS, Guarro J, Gene J, Figueras MJ (eds). Atlas of Clinical Fungi, 2nd edn. Utrecht/Reus : Centraalbureau voor Schimmelcutures/ Universitat Rovira I Virgili, 2000.
7. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard. NCCLS document M38-A. Wayne PA. Clinical and Laboratory Standards Institute, 2002.
8. Makimura K, Tamura Y, Mochizuki T, et al. Phylogenetic classification and species identification of dermatophyte strains based on DNA sequences of nuclear ribosomal internal transcribed spacer1 regions. J Clin Microbiol 1999; 37: 920-924.
9. Sugita C, Makimura K, Murakami A, et al. A case of pulmonary aspergilloma molecular biological identification and typing of the isolates from antemortem sputa and autopsy fungus ball. Mycoses 2003; 46: 149-152.
10. Voigt K, Cigelnik E, O'Donnell K. Phylogeny and PCR identification of clinically important zygomycetes based on nuclear ribosomal- DNA sequence data. J Clin Microbiol 1999; 37: 3957-3964.
11. Erdos MS, Butt K, Weinstein L. Mucormycotic endocarditis of the pulmonary valve. JAMA 1972; 222: 951-953.
12. Meyer RD, Kaplan MH, Ong M, Armstrong D. Cutaneous lesions in disseminated mucormycosis. JAMA 1973; 225: 737-738.
13. Kramer BS, Hernandez AD, Reddick RL, Levine AS. Cutaneous infarction: manifestation of disseminated mucormycosis. Arch Dermatol 1977; 113: 1075-1076.
14. Ryan ME, Ochs J. Primary cutaneous mucormycosis: superficial and gangrenous infections. Ped Infect Dis 1982; 1: 110-114.
15. del Palacio Hernanz A, Fereres J, Garraus SL, Rodriguez-Noriega A, Sanz Sanz F. Nosocomial infection by Rhizomucor pusillus in a clinical haematology unit. J Hosp Infect 1983; 4: 45-49.
16. Wickline CL, Cornitius TG, Butler T. Cellulitis caused by R hizomucor pusillus in a diabetic patient receiving continuous insulin infusion pump therapy. South Med J 1989; 82: 1432-1434.
17. Severo LC, Job F, Mattos TC. Systemic zygomycosis: nosocomial infection by Rhizomucor pusillus. Mycopathologia 1991; 113: 79-80.
18. Mimura M, Matsumoto M, Inkyo M, Yamamoto T. A case of pulmonary mucormycosis caused by Rhizomucor pusillus complicating with acute myelocytic leukemia. Igakukensa 1992; 41: 1440-1445.
19. St-Germain G, Robert A, Ishak M, Tremblay C, Claveau S. Infection due to Rhizomucor pusillus : report of four cases in patients with leukemia and review. Clin Infect Dis 1993; 16: 640-645.
20. Gonzalez CE, Couriel DR, Walsh TJ. Disseminated zygomycosis in a neutropenic patient: successful treatment with amphotericin B lipid complex and granulocyte colony-stimulating factor. Clin Infect Dis 1997; 24: 192-196.
21. Bjorkholm M, Runarsson G, Celsing F, et al. Liposomal amphotericin B and surgery in the successful treatment of invasive pulmonary mucormycosis in a patient with acute T-lymphoblastic leukemia. Scand J Infect Dis 2001; 33: 316-319.
22. Ma B, Seymour JF, Januszewicz H, Slavin MA. Cure of pulmonary Rhizomucor pusillus infection in a patient with hairy-cell leukemia: role of liposomal amphotericin B and GM-CSF. Leukemia Lymphoma 2001; 42: 1393-1399.
23. Iwen PC, Freifeld AG, Sigler L, Tarantolo SR. Molecular identification of Rhizomucor pusillus as a cause of sinus-orbital zygomycosis in a patient with acute myelogenous leukemia. J Clin Microbiol 2005; 43: 5819-5821.
24. Herbrecht R, Berthillot C, Fohrer C. Rhino-orbito-cerebral zygomycosis. J Invasive Fungal Infect 2007; 1: 17-18.
25. Green WR, Bouchette D. Pleural mucormycosis (zygomycosis). A rch Pathol Lab Med 1986; 110: 441-442.
26. Eucker J, Sezer O, Graf B, Possinger K. Mucormycosis. Mycoses 2000; 44: 253-260.
27. Tedder M, Spratt JA, Anstadt MP, et al. Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg 1994; 57: 1044-1050.